https://abbvie.indrap.org/lessons/introduction-to-the-course/2024-08-08T16:53:47+01:00https://abbvie.indrap.org/lessons/overview-whats-new-in-the-national-guideline/2024-08-08T16:57:05+01:00https://abbvie.indrap.org/lessons/hiv-diagnosis-within-the-community/2024-08-08T17:00:48+01:00https://abbvie.indrap.org/lessons/antiretroviral-therapy-in-nigeria/2024-08-08T17:04:30+01:00https://abbvie.indrap.org/lessons/antiretroviral-therapy-in-nigeria-unit-3-2/2024-08-08T17:24:28+01:00https://abbvie.indrap.org/lessons/antiretroviral-therapy-in-nigeria-unit-3-3/2024-08-08T17:03:35+01:00https://abbvie.indrap.org/lessons/co-morbidities/2024-08-08T17:09:39+01:00https://abbvie.indrap.org/lessons/adherence-to-antiretrovial-therapy/2024-08-08T17:11:14+01:00https://abbvie.indrap.org/lessons/lesson/2021-12-16T15:08:37+01:00https://abbvie.indrap.org/lessons/lesson-2/2021-12-16T15:54:20+01:00https://abbvie.indrap.org/lessons/lesson-one/2021-12-19T14:18:16+01:00https://abbvie.indrap.org/lessons/lesson-two/2021-12-19T14:18:42+01:00https://abbvie.indrap.org/lessons/lesson-three/2021-12-19T14:28:24+01:00https://abbvie.indrap.org/lessons/lesson-one-2/2021-12-19T23:01:00+01:00https://abbvie.indrap.org/lessons/lesson-two-2/2021-12-19T23:02:22+01:00https://abbvie.indrap.org/lessons/lesson-three-2/2021-12-19T23:03:04+01:00https://abbvie.indrap.org/lessons/introduction/2021-05-05T15:40:32+01:00https://abbvie.indrap.org/lessons/introduction-to-antiretroviral-therapy/2021-05-05T15:27:16+01:00https://abbvie.indrap.org/lessons/antiretroviral-therapy-toxicities-and-adherence/2021-05-05T15:27:37+01:00https://abbvie.indrap.org/lessons/differentiated-models-of-care/2021-05-05T15:27:53+01:00https://abbvie.indrap.org/lessons/introduction-to-treatment-failure-and-viral-load-monitoring/2021-05-05T15:36:32+01:00https://abbvie.indrap.org/lessons/antiretroviral-therapy-resistance/2021-05-05T15:36:51+01:00https://abbvie.indrap.org/lessons/switching-to-second-line-and-third-line-therapy/2021-05-05T15:37:11+01:00https://abbvie.indrap.org/lessons/principles-of-hiv-prevention/2021-05-05T15:37:29+01:00https://abbvie.indrap.org/lessons/understanding-pre-exposure-prophylaxis/2021-05-05T15:37:38+01:00https://abbvie.indrap.org/lessons/topical-issues-in-implementation-of-prep-in-nigeria/2021-05-05T15:38:04+01:00https://abbvie.indrap.org/lessons/antiretroviral-properties-of-integrase-inhibitors/2021-05-05T15:38:32+01:00https://abbvie.indrap.org/lessons/initiating-integrase-inhibitors-in-treatment-of-positive-patients/2021-05-05T15:38:59+01:00https://abbvie.indrap.org/lessons/new-strategies-in-managing-hiv-positive-children/2021-05-05T15:39:22+01:00https://abbvie.indrap.org/lessons/adolescent-care-and-long-term-hiv-management-success/2021-05-05T15:39:44+01:00https://abbvie.indrap.org/lessons/managing-hiv-and-hepatitis-b-virus-co-infection-new-trends/2021-05-05T15:40:05+01:00https://abbvie.indrap.org/lessons/hiv-and-covid-19/2021-05-05T15:40:12+01:00https://abbvie.indrap.org/lessons/introduction-2/2021-05-05T15:40:32+01:00https://abbvie.indrap.org/lessons/introduction-to-antiretroviral-therapy-2/2021-05-05T15:27:16+01:00https://abbvie.indrap.org/lessons/antiretroviral-therapy-toxicities-and-adherence-2/2021-05-05T15:27:37+01:00https://abbvie.indrap.org/lessons/differentiated-models-of-care-2/2021-05-05T15:27:53+01:00https://abbvie.indrap.org/lessons/introduction-to-treatment-failure-and-viral-load-monitoring-2/2021-05-05T15:36:32+01:00https://abbvie.indrap.org/lessons/antiretroviral-therapy-resistance-2/2021-05-05T15:36:51+01:00https://abbvie.indrap.org/lessons/switching-to-second-line-and-third-line-therapy-2/2021-05-05T15:37:11+01:00https://abbvie.indrap.org/lessons/principles-of-hiv-prevention-2/2021-05-05T15:37:29+01:00https://abbvie.indrap.org/lessons/understanding-pre-exposure-prophylaxis-2/2021-05-05T15:37:38+01:00https://abbvie.indrap.org/lessons/topical-issues-in-implementation-of-prep-in-nigeria-2/2021-05-05T15:38:04+01:00https://abbvie.indrap.org/lessons/antiretroviral-properties-of-integrase-inhibitors-2/2021-05-05T15:38:32+01:00https://abbvie.indrap.org/lessons/initiating-integrase-inhibitors-in-treatment-of-positive-patients-2/2021-05-05T15:38:59+01:00https://abbvie.indrap.org/lessons/new-strategies-in-managing-hiv-positive-children-2/2021-05-05T15:39:22+01:00https://abbvie.indrap.org/lessons/adolescent-care-and-long-term-hiv-management-success-2/2021-05-05T15:39:44+01:00https://abbvie.indrap.org/lessons/managing-hiv-and-hepatitis-b-virus-co-infection-new-trends-2/2021-05-05T15:40:05+01:00https://abbvie.indrap.org/lessons/hiv-and-covid-19-2/2021-05-05T15:40:12+01:00https://abbvie.indrap.org/lessons/introduction-to-covid-19/2021-05-05T11:45:04+01:00https://abbvie.indrap.org/lessons/current-situation-of-covid-19-outbreak-in-nigeria/2021-05-05T11:45:20+01:00https://abbvie.indrap.org/lessons/case-definition/2021-05-05T11:45:53+01:00https://abbvie.indrap.org/lessons/isolation-and-notification/2021-05-05T11:50:12+01:00https://abbvie.indrap.org/lessons/design-and-workflow-of-isolation-facility/2021-05-05T11:50:26+01:00https://abbvie.indrap.org/lessons/overview-of-infection-prevention-and-control/2021-05-05T11:50:48+01:00https://abbvie.indrap.org/lessons/hand-hygiene/2021-05-05T11:50:56+01:00https://abbvie.indrap.org/lessons/use-of-personal-protective-equipment/2021-05-05T11:51:12+01:00https://abbvie.indrap.org/lessons/disinfection-and-environmental-cleaning/2021-05-05T11:51:28+01:00https://abbvie.indrap.org/lessons/safe-management-of-linens/2021-05-05T11:51:42+01:00https://abbvie.indrap.org/lessons/waste-management/2021-05-05T11:51:50+01:00https://abbvie.indrap.org/lessons/management-of-suspected-and-confirmed-cases/2021-05-05T11:52:14+01:00https://abbvie.indrap.org/lessons/specimen-collection-packaging-and-transportation/2021-05-05T11:53:05+01:00https://abbvie.indrap.org/lessons/psychosocial-support-for-covid-19-patients-and-healthcare-staff/2021-05-05T11:53:24+01:00https://abbvie.indrap.org/lessons/safe-transfer-of-patients/2021-05-05T11:53:37+01:00https://abbvie.indrap.org/lessons/management-of-dead-bodies/2021-05-05T11:53:52+01:00https://abbvie.indrap.org/lessons/introduction-to-covid-19-2/2021-05-05T11:45:04+01:00https://abbvie.indrap.org/lessons/current-situation-of-covid-19-outbreak-in-nigeria-2/2021-05-05T11:45:20+01:00https://abbvie.indrap.org/lessons/case-definition-2/2021-05-05T11:45:53+01:00https://abbvie.indrap.org/lessons/isolation-and-notification-2/2021-05-05T11:50:12+01:00https://abbvie.indrap.org/lessons/design-and-workflow-of-isolation-facility-2/2021-05-05T11:50:26+01:00https://abbvie.indrap.org/lessons/overview-of-infection-prevention-and-control-2/2021-05-05T11:50:48+01:00https://abbvie.indrap.org/lessons/hand-hygiene-2/2021-05-05T11:50:56+01:00https://abbvie.indrap.org/lessons/use-of-personal-protective-equipment-2/2021-05-05T11:51:12+01:00https://abbvie.indrap.org/lessons/disinfection-and-environmental-cleaning-2/2021-05-05T11:51:28+01:00https://abbvie.indrap.org/lessons/safe-management-of-linens-2/2021-05-05T11:51:42+01:00https://abbvie.indrap.org/lessons/waste-management-2/2021-05-05T11:51:50+01:00https://abbvie.indrap.org/lessons/management-of-suspected-and-confirmed-cases-2/2021-05-05T11:52:14+01:00https://abbvie.indrap.org/lessons/specimen-collection-packaging-and-transportation-2/2021-05-05T11:53:05+01:00https://abbvie.indrap.org/lessons/psychosocial-support-for-covid-19-patients-and-healthcare-staff-2/2021-05-05T11:53:24+01:00https://abbvie.indrap.org/lessons/safe-transfer-of-patients-2/2021-05-05T11:53:37+01:00https://abbvie.indrap.org/lessons/management-of-dead-bodies-2/2021-05-05T11:53:52+01:00https://abbvie.indrap.org/lessons/introduction-to-the-course-2/2021-05-19T00:03:14+01:00https://abbvie.indrap.org/lessons/overview-whats-new-in-the-national-guideline-2/2021-05-19T00:04:23+01:00https://abbvie.indrap.org/lessons/hiv-diagnosis-within-the-community-2/2021-05-19T00:05:13+01:00https://abbvie.indrap.org/lessons/antiretroviral-therapy-in-nigeria-2/2021-05-19T00:06:45+01:00https://abbvie.indrap.org/lessons/antiretroviral-therapy-in-nigeria-unit-3-2-2/2021-05-28T10:23:21+01:00https://abbvie.indrap.org/lessons/antiretroviral-therapy-in-nigeria-unit-3-3-2/2021-05-28T10:23:35+01:00https://abbvie.indrap.org/lessons/co-morbidities-2/2021-05-19T00:07:31+01:00https://abbvie.indrap.org/lessons/adherence-to-antiretrovial-therapy-2/2021-05-19T00:08:35+01:00